CHABAIDAO Publishes 2025 AGM Agenda: Board Reshuffle, Dual Share Mandates and Supervisory Committee Abolition on Ballot

Bulletin Express
04/29

Sichuan Baicha Baidao Industrial Co., Ltd. (abbreviated as CHABAIDAO) has issued the proxy form and agenda for its 2025 Annual General Meeting, scheduled for 2:00 p.m. on 21 May 2026 at the company’s headquarters in Chengdu.

Key agenda items are divided into ordinary and special resolutions:

1. Routine Reporting • Shareholders will vote on the 2025 Annual Report, the Board of Directors’ Report, the Supervisory Committee’s Report, the Final Accounts Report and the Profit Distribution Plan for 2025. • Re-appointment of the external auditor for the 2026 financial year is proposed.

2. Board Restructuring • Eight directors are nominated for the third board term: Mr. Wang Xiaokun, Mr. Wang Hongxue, Ms. Dai Li and Mr. Chen Keyuan as executive directors; Dr. Chen Da as non-executive director; and Mr. Yeung Chi Tat, Dr. Tang Yong and Ms. Cheng Li as independent non-executive directors. • A corresponding remuneration package for the new board is up for approval.

3. Corporate Governance Updates • Amendments to the Rules of Procedure for Shareholders’ General Meetings and for the Board of Directors are proposed. • A special resolution seeks to abolish the Supervisory Committee, accompanied by amendments to the Articles of Association.

4. Capital Management Authorities • Shareholders will consider granting a general mandate to the board to issue additional shares. • A parallel mandate would authorize the company to repurchase its own shares within regulatory limits.

Shareholders of CHABAIDAO’s H-shares who wish to vote by proxy must lodge the completed form with Computershare Hong Kong Investor Services Limited no less than 24 hours before the meeting. Personal attendance remains an option, subject to presentation of valid identification.

免責聲明:投資有風險,本文並非投資建議,以上內容不應被視為任何金融產品的購買或出售要約、建議或邀請,作者或其他用戶的任何相關討論、評論或帖子也不應被視為此類內容。本文僅供一般參考,不考慮您的個人投資目標、財務狀況或需求。TTM對信息的準確性和完整性不承擔任何責任或保證,投資者應自行研究並在投資前尋求專業建議。

熱議股票

  1. 1
     
     
     
     
  2. 2
     
     
     
     
  3. 3
     
     
     
     
  4. 4
     
     
     
     
  5. 5
     
     
     
     
  6. 6
     
     
     
     
  7. 7
     
     
     
     
  8. 8
     
     
     
     
  9. 9
     
     
     
     
  10. 10